| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 646 companies in the Biotechnology industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | MPLT Maplight Therapeutics, Inc. | Catalyst4, Inc. | 10% Owner | Buy | 1,209,225 | $12.66 | $15,314,793.77 | +1.5% | - | - | |
| Jul 29, 2026 | MAZE Maze Therapeutics, Inc. | Dandekar Atul | Csbo | Sell | 7,500 | $27.34 | $205,031.44 | -12.4% | - | - | |
| Jul 29, 2026 | HCWB Hcw Biologics Inc. | Wong Hing C | Chief Executive Officer | Buy | 23,210 | $2.59 | $59,997.85 | +22.6% | - | - | |
| Jul 29, 2026 | HCWB Hcw Biologics Inc. | Flowers Lee | SVP Of Business Development | Buy | 7,736 | $2.59 | $19,997.56 | +810.1% | - | - | |
| Jul 29, 2026 | BCDA Biocardia, Inc. | Altman Peter46 | President And CEO | Buy | 5,000 | $0.78 | $3,900.00 | +1.4% | - | - | |
| Jul 29, 2026 | DBVTF Dbv Technologies | Mohideen Pharis46 | Chief Medical Officer | Sell | 464 | $2.70 | $1,252.80 | -0.3% | - | - | |
| Jul 29, 2026 | VKTX Viking Therapeutics, Inc. | Zante Greg53 | Chief Financial Officer | Sell | 21,217 | $33.47 | $710,141.48 | -9.1% | - | - | |
| Jul 29, 2026 | VKTX Viking Therapeutics, Inc. | Lian Brian52 | President &CEO | Sell | 148,517 | $33.32 | $4,947,888.41 | -5.5% | - | - | |
| Jul 29, 2026 | PRTA Prothena Corporation Plc | Kingston Anne Evans | Chief Strategy Officer | Sell | 7,662 | $8.47 | $64,919.36 | -12.1% | - | - | |
| Jul 29, 2026 | GLSI Greenwich Lifesciences, Inc. | Patel Snehal61 | CEO And CFO | Buy | 2,200 | $13.43 | $29,555.00 | - | - | - | |
| Jul 29, 2026 | PRTA Prothena Corporation Plc | Isaacs Michael John | General Counsel &Company Sec. | Sell | 8,386 | $8.47 | $71,055.42 | -19.0% | - | - | |
| Jul 29, 2026 | VKTX Viking Therapeutics, Inc. | Mancini Marianna53 | Chief Operating Officer | Sell | 18,217 | $33.47 | $609,635.55 | -4.1% | - | - | |
| Jul 28, 2026 | MPLT Maplight Therapeutics, Inc. | Cox Troy | Director | Buy | 15,620 | $9.52 | $148,702.40 | New | - | - | |
| Jul 28, 2026 | EDIT Editas Medicine, Inc. | Burkly Linda48 | EVP, Chief Scientific Officer | Sell | 4,928 | $2.67 | $13,157.76 | -7.3% | - | - | |
| Jul 28, 2026 | SCTX Scribe Therapeutics Inc. | Aghazadeh Behzad | Director, 10% Owner, See Remarks | Buy | 2,391,238 | $15.16 | $36,259,761.25 | +35.1% | - | - | |
| Jul 27, 2026 | ROIV Roivant Sciences Ltd. | Venker Eric | President &Immunovant CEO | Sell | 200,000 | $34.95 | $6,990,000.00 | -11.0% | - | - | |
| Jul 27, 2026 | SCTX Scribe Therapeutics Inc. | Orbimed Advisors LLC66 | Director | Buy | 1,000,000 | $15.00 | $15,000,000.00 | +286.7% | - | - | |
| Jul 27, 2026 | GLSI Greenwich Lifesciences, Inc. | Patel Snehal61 | CEO And CFO | Buy | 1,500 | $13.62 | $20,430.00 | - | - | - | |
| Jul 27, 2026 | SCTX Scribe Therapeutics Inc. | Ah Bio Fund Ii, L.P. | 10% Owner | Buy | 333,333 | $15.00 | $4,999,995.00 | +16.2% | - | - | |
| Jul 27, 2026 | AVTX Avalo Therapeutics, Inc. | Doyle Mittie | Chief Medical Officer | Sell | 1,000 | $20.00 | $20,000.00 | -1.9% | - | - | |
| Jul 27, 2026 | ANIX Anixa Biosciences, Inc. | Kumar Amit62 | Chief Executive Officer | Buy | 5,000 | $3.44 | $17,200.00 | +0.8% | - | - | |
| Jul 27, 2026 | PCVX Vaxcyte, Inc. | Pickering Grant50 | Chief Executive Officer | Sell | 18,198 | $55.63 | $1,012,375.29 | -1.2% | - | - | |
| Jul 27, 2026 | BEAM Beam Therapeutics Inc. | Simon Amy56 | Chief Medical Officer | Sell | 16,667 | $25.74 | $429,036.91 | -16.3% | - | - | |
| Jul 27, 2026 | MLTX Moonlake Immunotherapeutics | Reich Kristian78 | Chief Scientific Officer | Sell | 1,100 | $20.00 | $22,000.00 | - | - | - | |
| Jul 27, 2026 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham | Chief Executive Officer | Sell | 2,210 | $42.11 | $93,060.87 | -0.2% | - | - |